📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

The epithelial splicing regulator ESRP2 is epigenetically repressed by DNA hypermethylation in Wilms tumour and acts as a tumour suppressor. (2022)

First Author: Legge D

Attributed to: Anti-angiogenic compounds based on modulation of VEGF splicing funded by BBSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1002/1878-0261.13101

PubMed Identifier: 34520622

Publication URI: http://europepmc.org/abstract/MED/34520622

Type: Journal Article/Review

Volume: 16

Parent Publication: Molecular oncology

Issue: 3

ISSN: 1574-7891